We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.
As of the United Nations bulletin on May 22nd, 2022, there have been 92 confirmed cases and 28 suspected cases in 12 non-monkeypox virus endemic countries around the world since May 13th (Table 1 for details) as reported by the World Health Organization (WHO). So far, there have been no related deaths.
Table1. Monkeypox cases in non-endemic countries reported to WHO from 13:00 on May 13 to 21, 2022. Source: Vazyme Biotech Co. Ltd.
From December 15th, 2021, to May 1st, 2022 (as shown in Table 2), there have been four African countries with a monkeypox epidemic, which have reported 1315 confirmed cases to WHO. There is no travel history in endemic countries among the currently reported confirmed and suspected patients in non-endemic countries.
To date, existing cases have largely been found among men who have sex with men. People who have close physical contact with symptomatic cases are likely to catch the virus, and this mode of transmission is likely to be partly responsible for the spread.
Table 2. Monkeypox cases in endemic countries from December 15, 2021, to May 1, 2022. Source: Vazyme Biotech Co. Ltd.
Monkeypox virus belongs to the Orthopoxvirus genus of the Poxviridae family and is an enveloped double-stranded DNA virus. The monkeypox virus has two distinct genetic clades: the west African clade and the central African (Congo Basin) clade. Cameroon is, to date, the only country where both virus clades have been found concurrently.
Figure 1. The structure map of monkeypox virus. Image Credit: Chinanews.com
Monkeypox has emerged as the most important orthopoxvirus for public health, with the eradication of smallpox in 1980 and subsequent cessation of smallpox vaccination.
As a zoonotic orthopoxvirus, monkeypox has an incubation period of 6 to 13 days. It is characterized in the early stages by intense headache, lymphadenopathy (swelling of the lymph nodes), fever, muscle aches, and intense asthenia.
A few days after fever, typical systemic purulent herpes usually begins, which can lead to secondary infection. Within the general population, the fatality ratio of monkeypox has ranged from 0 to 11 % and has been found to be higher among young children.
Image Credit: Picture uploaded by NetEase Hao netizen
Damaged skin, respiratory tract or mucous membrane (eyes, nose or mouth) can all be modes of monkeypox virus transmission. The three main modes of transmission are:
The typical incubation period of the monkeypox virus is 6 to 13 days but can be as many as 21 days. It was reported both in local media and national outlets like The Guardian and local media reports on the 22nd that the British health and safety agency has proposed that anyone discovering that they have had close contact with or are living together with confirmed cases of monkeypox should self-isolate for 21 days.
It is vital that monkeypox is diagnosed in good time to inhibit the spread and minimize the impact.
The first step of diagnosis is the clinical identification of monkeypox. This confirmation of monkeypox requires a range of different laboratory tests, including virus isolation from cell culture, polymerase chain reaction (PCR) analysis, antigen detection test and an enzyme-linked immunosorbent assay (ELISA).
It is important to note that monkeypox-specific confirmation is not provided by antigen and antibody detection methods due to the serological cross-reactivity of orthopoxviruses. Therefore, in investigations where resources are limited, antigen and serology detection methods are not recommended for diagnosis or case.
The existence of the virus can only be confirmed by PCR and virus isolation from cell culture. Of these, PCR is the preferred laboratory test as a result of its sensitivity and accuracy. Vesicles, blood specimens, pustular fluid, and scab specimens all provide samples of monkeypox, but the optimal diagnostic is from skin lesions – the fluid or roof from vesicles and pustules, as well as dry crusts.
Many IVD companies have developed monkeypox virus nucleic acid detection kits since the outbreak of the monkeypox virus. Vazyme, as a supplier of professional solutions and raw materials within the fields of biomedicine, life science, and in vitro diagnosis, is able to provide clients with a full set of solutions.
These solutions include positive control, amplification reagents, and primer probe design, all of which are required for product development when attempting to generate monkeypox diagnosis to help clients rapidly complete their product development.
Table 4. Source: Vazyme Biotech Co. Ltd.
Animal Detection U+ Probe qPCR Super PreMix（QV114）
The Vazyme#QV114 premixed primer probe was processed by process of repeated freezing and thawing 30 times and pressure at 37 ℃ for seven days, respectively, with the dual quality control system. The control was the premixed solution stored at -20 ℃, which was carried out on the same board.
It was shown by the results that the Vazyme#QV114 premixed primer probe after the corresponding treatment had no significant difference from the control group: showing the reagent had better premixed stability.
Image Credit: Vazyme Biotech Co. Ltd.
Vazyme#QV114 and other brand probe qPCR reagents (T、TA) were used for amplification under the same reaction conditions, with blood DNA virus as the template. It was revealed by the results that Vazyme#QV114 had both a higher amplification platform and detection sensitivity in comparison to similar products.
Image Credit: Vazyme Biotech Co. Ltd.
Since the establishment in 2012, Vazyme has been dedicated to our mission "Science and Technology Make a Healthier Life" to focus on technology innovation and continuously expand the application fields of core technologies in life science, bio-medicine, and in vitro diagnostics.
As a R&D based company, we have been holding ourselves to the highest standards of ethics, accountability and professionalism. Our global research and development operations make sure we could provide quality products, solutions, and services locally to our customers, and more importantly, to do as much as it can to meet the unmet customers’ needs. For now, we are present in more than 60 countries and regions worldwide to get close to local customers.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.
Last updated: Jun 28, 2022 at 8:45 AM
Please use one of the following formats to cite this article in your essay, paper or report:
Vazyme Biotech Co. Ltd.. (2022, June 28). Insights into Monkeypox. News-Medical. Retrieved on July 02, 2022 from https://www.news-medical.net/whitepaper/20220628/Monkeypox-explained.aspx.
Vazyme Biotech Co. Ltd.. "Insights into Monkeypox". News-Medical. 02 July 2022. <https://www.news-medical.net/whitepaper/20220628/Monkeypox-explained.aspx>.
Vazyme Biotech Co. Ltd.. "Insights into Monkeypox". News-Medical. https://www.news-medical.net/whitepaper/20220628/Monkeypox-explained.aspx. (accessed July 02, 2022).
Vazyme Biotech Co. Ltd.. 2022. Insights into Monkeypox. News-Medical, viewed 02 July 2022, https://www.news-medical.net/whitepaper/20220628/Monkeypox-explained.aspx.
Fasters Super-Fidelity DNA Polymerase to achieve rapid amplification performance
Meeting growing demand for high-quality quantitative real-time PCR with Taq Pro Universal SYBR qPCR Master Mix
As part of our SLAS Europe 2022 coverage, we speak to Dr. Javier Terriente, Co-founder and Chief of Drug Development at ZeClinics, about how zebrafish could be the future for discovering new therapeutics.
In this interview, News-Medical talks to Adrienne Sherk about how Unite Us has created an efficient system of care within communities to improve health.
As part of our SLAS Europe 2022 coverage, we speak to Ian Shuttler from Tecan about their new MagicPrepTM NGS technology.
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.
This site complies with the HONcode standard for trustworthy health information: verify here.
News-Medical.net - An AZoNetwork Site
Owned and operated by AZoNetwork, © 2000-2022